Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Kaiser Daily Global Health Policy ReportVaccines Search Results « » The Henry J. Kaiser Family Foundation

Vaccines

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Asia’s Largest Vaccine Maker Developing Low-Cost HPV, Diarrheal, Pneumococcal Vaccines

Bloomberg Businessweek: Top-Selling Vaccine Made Cheap Shows Challenge to Merck: Health “…Serum Institute of India Ltd., which makes vaccines injected in 65 percent of the world’s children, is targeting newer vaccines, including one for the human papillomavirus that could be available in late 2018 and sell at a third of…

10 Advances In Global Health, Vaccinations For 2015

Huffington Post: 2015: Full Speed Ahead Orin Levine, director of vaccine delivery at the Bill & Melinda Gates Foundation “…I compiled a quick list of the 10 advances in global health and vaccinations I would like to see in 2015: 1. A fully-funded Gavi, the Vaccine Alliance; 2. An end…

Gates Annual Letter Should Prompt Discussion About West’s Role In Poverty Eradication

Washington Post: Grading the 2015 Bill and Melinda Gates letter on poverty alleviation Chris Blattman, associate professor of political science and international and public affairs at Columbia University “…[T]o preview, my overall grade [of the Bill and Melinda Gates annual letter] is a B. … By 2030, probably half the…

Gavi Requests $7.5B From Donors As Funding Conference Approaches

Reuters: Vaccines group seeks $7.5 billion as disease fight reaches peak “The Gavi global vaccines alliance is seeking to raise $7.5 billion at a funding conference in Berlin next week, as its battle to prevent infectious diseases in millions of children reaches an expected peak. … The coming 2016-20 period…

Experts At European Parliament Session Outline Challenges In TB Drug Development

EurActiv: Developing countries urged to produce TB vaccines locally “Even though one third of the global population have the microbes that cause tuberculosis (TB), pharmaceutical companies still have little incentive to produce the drugs that can combat the deadly but curable disease. Speaking at the European Parliament on Wednesday (21…